Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer

Jazbec J, Todorovski L, Jereb B. Classification tree analysis of second neoplasms in survivors of childhood cancer. BMC Cancer 2007; 7: 1-6.10.1186/1471-2407-7-27Search in Google Scholar

Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000; 18: 2435-43.10.1200/JCO.2000.18.12.2435Search in Google Scholar

Boussen H, Kochbati L, Besbes M, Dhiab T, Makhlouf R, Jerbi G, et al. [Male secondary breast cancer after treatment for Hodgkin's disease. Case report and review of the literature]. [French]. Cancer Radiother 2000; 4: 465-8.10.1016/S1278-3218(00)00018-4Search in Google Scholar

Ozet A, Yavuz AA, Kömürcü S, Oztürk B, Safali M, Arpaci F, et al. Bilateral male breast cancer and prostate cancer: a case report. Jpn J Clin Oncol 2000; 30: 188-90.10.1093/jjco/hyd05010830988Search in Google Scholar

Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 20-26.10.1158/1055-9965.20.14.1Search in Google Scholar

Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137: 678-87.10.7326/0003-4819-137-8-200210150-0001312379069Search in Google Scholar

Leinung S, Horn LC, Backe J. [Male breast cancer: history, epidemiology, genetic and histopathology]. [German]. Zentralbl Chir 2007; 132: 379-85.10.1055/s-2007-98126017907078Search in Google Scholar

Murata H, Khattar NH, Gu L, Li GM. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett 2005; 223: 143-50.10.1016/j.canlet.2004.09.03915890247Search in Google Scholar

Latz D, Alfrink M, Nassar N, Beyerle C. Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation. Onkologie 2004; 27: 477-9.Search in Google Scholar

Zebic-Sinkovec M, Kadivec M, Podobnik G, Skof E, Snoj M. Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI: a case report. Radiol Oncol 2010; 44: 228-31.10.2478/v10019-010-0033-9342370622933920Search in Google Scholar

Thomas DB, Rosenblatt K, Jimenez LM, McTiernan A, Stalsberg H, Stemhagen A, et al. Ionizing radiation and breast cancer in men (United States). Cancer Causes and Control 1994; 5: 9-14.10.1007/BF018307218123783Search in Google Scholar

Eeles RA. Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2000; 2: 283-90.10.1186/bcr7013878911250722Search in Google Scholar

Malkin D. The role of p53 in human cancer. J Neurooncol 2001; 51: 231-43.10.1023/A:1010636426860Search in Google Scholar

Zager V, Cemazar M, Hreljac I, Lah TT, Sersa G, Filipic M. Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression. Radiol Oncol 2010; 44: 42-51.10.2478/v10019-010-0010-3Search in Google Scholar

Cesar Paz-y-Mino, Perez CJ, Fiallo BF, Leone PE. A polymorphism in the hMSH2 gene (gIVS12-6T>C) associated with non-Hodgkin lymphomas. Cancer Genet Cytogenet 2002; 133: 29-33.10.1016/S0165-4608(01)00547-7Search in Google Scholar

Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP, et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 2003; 9: 3012-20.Search in Google Scholar

Ollila S, Delmadi Bebek D, Jiricny J, Nystrom M. Mechanisms of pathogenicity in human MSH2 missense mutants. Human Mutation 2008: 29: 1355-63.10.1002/humu.2089318951462Search in Google Scholar